IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 46 filers reported holding IRADIMED CORP in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $530,576 | -8.5% | 11,958 | -1.5% | 0.00% | – |
Q2 2023 | $579,707 | -27.1% | 12,143 | -39.9% | 0.00% | – |
Q1 2023 | $795,459 | +65.4% | 20,215 | +18.9% | 0.00% | – |
Q4 2022 | $481,000 | +18.5% | 16,999 | +25.9% | 0.00% | – |
Q3 2022 | $406,000 | -12.3% | 13,500 | -1.0% | 0.00% | – |
Q2 2022 | $463,000 | -49.2% | 13,636 | -32.9% | 0.00% | – |
Q1 2022 | $912,000 | -84.8% | 20,334 | -93.0% | 0.00% | -100.0% |
Q2 2018 | $5,987,000 | -9.7% | 288,566 | -38.7% | 0.00% | 0.0% |
Q1 2018 | $6,632,000 | -6.5% | 470,382 | +0.5% | 0.00% | 0.0% |
Q4 2017 | $7,090,000 | +61.7% | 467,982 | +2.4% | 0.00% | +50.0% |
Q3 2017 | $4,386,000 | +48.5% | 456,810 | +32.9% | 0.00% | +100.0% |
Q2 2017 | $2,954,000 | +257.2% | 343,620 | +361.2% | 0.00% | – |
Q4 2016 | $827,000 | -25.4% | 74,500 | +14.3% | 0.00% | -100.0% |
Q3 2016 | $1,108,000 | -14.9% | 65,200 | +9.0% | 0.00% | 0.0% |
Q2 2016 | $1,302,000 | +14.6% | 59,830 | +0.9% | 0.00% | 0.0% |
Q1 2016 | $1,136,000 | +15.1% | 59,300 | +68.5% | 0.00% | 0.0% |
Q4 2015 | $987,000 | – | 35,195 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nine Ten Capital Management LLC | 783,066 | $30,814,000 | 5.13% |
Soleus Capital Management, L.P. | 773,694 | $30,444,859 | 3.15% |
RK Capital | 335,400 | $13,197,990 | 2.90% |
Capital Impact Advisors, LLC | 19,390 | $762,997 | 0.94% |
Ranger Investment Management | 205,692 | $8,093,980 | 0.54% |
Bares Capital Management | 317,000 | $12,473,950 | 0.44% |
Hillsdale Investment Management Inc. | 109,100 | $4,293,085 | 0.37% |
CORNERCAP INVESTMENT COUNSEL INC | 37,007 | $1,456,225 | 0.26% |
Riverwater Partners LLC | 6,234 | $245,308 | 0.22% |
RICE HALL JAMES & ASSOCIATES, LLC | 72,271 | $2,843,864 | 0.16% |